You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in Branded Drug ALLERGY RELIEF-D


✉ Email this page to a colleague

« Back to Dashboard


Generic Drugs Containing ALLERGY RELIEF-D

Excipient Strategy and Commercial Opportunities for Allergy Relief-D

Last updated: February 28, 2026

What is the role of excipients in Allergy Relief-D formulations?

Excipients in Allergy Relief-D serve multiple functions: they improve drug stability, enhance bioavailability, facilitate manufacturing, and ensure patient compliance. Common excipients include fillers (lactose, microcrystalline cellulose), binders (polyvinylpyrrolidone), disintegrants (crospovidone), lubricants (magnesium stearate), and flavoring agents. Formulation choices depend on the dosage form—tablet, capsule, or oral solution.

How do excipient choices influence regulatory approval and patent strategy?

Regulatory authorities restrict certain excipients due to safety or tolerability concerns. Ensuring excipients are generally recognized as safe (GRAS) or approved regulators' excipient lists reduces approval risk. Novel excipients or unique combinations can create patent opportunities by protecting formulation innovations, extending lifecycle, and differentiating the product.

What are key commercial opportunities arising from excipient innovation?

  1. Enhanced Stability and Shelf Life: Use of excipients like stabilizers or antioxidants extends product shelf life, reducing supply chain costs and waste.

  2. Improved Patient Experience: Flavoring agents or rapid disintegration excipients increase palatability and adherence, especially in pediatric or sensitive populations.

  3. Formulation Differentiation: Novel excipients can enable new delivery formats—liquid gels or chewables—that appeal to specific market segments.

  4. Patent Protection: Proprietary excipient combinations or novel formulations can lead to strong intellectual property rights, delaying generic competition.

  5. Manufacturing Efficiency: Excipient optimizations can streamline processes, lower production costs, and increase margins.

What are current trends in excipient strategy for allergy medications?

  • Use of Biocompatible or Natural Excipients: Shift toward plant-based or biodegradable excipients to meet consumer demand and regulatory preferences.
  • Moisture-Control Agents: Incorporate silica or other desiccants to improve stability.
  • Taste Masking Technologies: Apply polymer coatings or complexing agents for better flavor profiles.
  • Specialized Disintegrants: Use superdisintegrants like sodium starch glycolate for rapid dissolution.

How does excipient selection impact manufacturing and commercialization?

Selection affects scalability, formulation robustness, and regulatory pathways. Consistency in excipient sourcing prevents batch variability. Compatibility with active ingredients prevents interactions that could compromise potency or safety. Compatibility with global regulatory standards accelerates approval processes.

What regulatory considerations influence excipient strategy?

  • Compliance with US FDA, EMA, and other regional guidelines.
  • Use of excipients listed on approved sources.
  • Documentation of excipient safety and manufacturing controls.
  • Potential need for safety data for new excipients or novel combinations.

Summary of formulation and commercial considerations

Aspect Impact
Regulatory Compliance Access to global markets with fewer hurdles
Patent Protection Exclusive rights through novel excipient combinations
Market Differentiation Better patient adherence and experience
Cost Efficiency Streamlined manufacturing reduces costs

Key Takeaways

  • Excipients influence drug stability, delivery, regulatory approval, and patentability.
  • Formulation innovation, especially with novel excipients, can create competitive advantages.
  • Consumer preferences favor natural or biodegradable excipients, impacting strategy.
  • Ensuring regulatory compliance is critical for smooth commercialization.
  • Differentiation via excipient technology can expand market share and improve margins.

FAQs

1. What are the most common excipients in allergy relief formulations?
Lactose, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, and flavoring agents.

2. Can excipient modifications extend shelf life?
Yes, antioxidants and stabilizers prevent degradation, extending stability.

3. Are natural excipients favored in allergy relief products?
Increasingly, yes, driven by consumer demand and regulatory shifts toward biocompatible ingredients.

4. How do patent laws influence excipient selection?
Patentability improves with unique combinations or novel excipients; otherwise, patent life may be limited.

5. What regulatory agencies govern excipient approval?
US FDA, EMA, and regional agencies maintain lists of approved excipients; new excipients require safety data.

References

[1] U.S. Food and Drug Administration. (2021). Guidance for Industry: Excipients in Food for Human Consumption.
[2] European Medicines Agency. (2022). Overview of the regulation of excipients.
[3] USP-NF. (2022). List of excipients acceptable for pharmaceutical use.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.